These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders. Ogawa R; Akaishi S Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277 [TBL] [Abstract][Full Text] [Related]
5. Revealing the pathogenesis of keloids based on the status: Active vs inactive. Oh S; Yeo E; Shim J; Noh H; Park J; Lee KT; Kim SH; Lee D; Lee JH Exp Dermatol; 2024 May; 33(5):e15088. PubMed ID: 38685820 [TBL] [Abstract][Full Text] [Related]
6. Endothelial-to-mesenchymal transition induced by Wnt 3a in keloid pathogenesis. Lee WJ; Park JH; Shin JU; Noh H; Lew DH; Yang WI; Yun CO; Lee KH; Lee JH Wound Repair Regen; 2015; 23(3):435-42. PubMed ID: 25845828 [TBL] [Abstract][Full Text] [Related]
7. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. Meyer LJ; Russell SB; Russell JD; Trupin JS; Egbert BM; Shuster S; Stern R J Invest Dermatol; 2000 May; 114(5):953-9. PubMed ID: 10771477 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option. Dienus K; Bayat A; Gilmore BF; Seifert O Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. Yu H; Bock O; Bayat A; Ferguson MW; Mrowietz U J Plast Reconstr Aesthet Surg; 2006; 59(3):221-9. PubMed ID: 16676428 [TBL] [Abstract][Full Text] [Related]
10. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models. Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604 [TBL] [Abstract][Full Text] [Related]
11. Annexin A2 participates in human skin keloid formation by inhibiting fibroblast proliferation. Kim SH; Jung SH; Chung H; Jo DI; Kim CK; Park SH; Won KJ; Jeon HS; Kim B Arch Dermatol Res; 2014 May; 306(4):347-57. PubMed ID: 24402284 [TBL] [Abstract][Full Text] [Related]
12. Keloids show regional distribution of proliferative and degenerate connective tissue elements. Bux S; Madaree A Cells Tissues Organs; 2010; 191(3):213-34. PubMed ID: 19641294 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Fujiwara M; Muragaki Y; Ooshima A Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401 [TBL] [Abstract][Full Text] [Related]
15. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405 [TBL] [Abstract][Full Text] [Related]
16. The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts. Gauglitz GG; Bureik D; Zwicker S; Ruzicka T; Wolf R Skin Pharmacol Physiol; 2015; 28(3):115-23. PubMed ID: 25502330 [TBL] [Abstract][Full Text] [Related]